17-Year Follow-up Study of a Patient with Obstructive Hypertrophic Cardiomyopathy with a Deletion Mutation in the Cardiac Myosin Binding Protein C Gene

Circulation Journal

Volumn 68, Issue 2, 2004, Pages 174-177

  Ogimoto, Akiyoshi ^a   Hamada, Mareomi ^a   Nakura, Jun ^a   Shigematsu, Yuji ^a   Hara, Yuji ^a   Ohtsuka, Tomoaki ^a   Morishima, Atsuyuki ^a   Kimura, Akinori ^b   Miki, Tetsuro ^a   Hiwada, Kunio ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Heart failure; Hypertrophic obstructive cardiomyopathy; Myosin binding protein C

Indexed keywords

CARDIAC MYOSIN; CARDIAC MYOSIN BINDING PROTEIN C; MYOSIN BINDING PROTEIN C; THYMIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIAC MYOSIN BINDING PROTEIN C GENE; CASE REPORT; CHRONIC HEART ATRIUM FIBRILLATION; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; EXON; FOLLOW UP; GENE; GENE DELETION; GENE MUTATION; HEART ATRIUM FIBRILLATION; HEART DILATATION; HEART HYPERTROPHY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MECHANOCARDIOGRAPHY; PAROXYSMAL HEART ATRIUM FIBRILLATION;

ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FOLLOW-UP STUDIES; FRAMESHIFT MUTATION; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR REMODELING;

EID: 10744226925     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.174     Document Type: Article

References (18)

1. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Biochem Biophys Res Commun 1999; 262: 411-417.
2. Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994; 93: 280-285.
3. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, et al. Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332: 1058-1064.
4. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998; 338: 1248-1257.
5. Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Fischer C, et al. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy: Characterization of cardiac transcript and protein. J Clin Invest 1997; 100: 475-482.
6. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, et al. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997; 80: 427-434.
7. Charron P, Dubourg O, Desnos M, Bennaceur M, Carrier L, Camproux A-C, et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998; 97: 2230-2236.
8. Doi YL, Kitaoka H, Hitomi N, Satoh M, Kimura A. Clinical expression in patients with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutation. Circulation 1999; 100: 448-449.
9. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987; 59: 123-129.
10. Seiler C, Jenni R, Vassalli G, Turina M, Hess OM. Left ventricular chamber dilatation in hypertrophic cardiomyopathy: Related variables and prognosis in patients with medical and surgical therapy. Br Heart J 1995; 74: 508-516.
11. Kawai M, Kihara Y, Hasegawa K, Matsumori A, Sasayama S. Dilated phase of hypertrophic cardiomyopathy with mid-ventricular obstruction after 20-year follow-up. Jpn Circ J 2000; 64: 623-626.
12. Hamada M, Shigematsu Y, Fujiwara Y, Sumimoto T, Hiwada K, Kokubu T. Persistent elevation of cardiac enzymes in a patient with hypertrophic cardiomyopathy: With special reference to electrocardiographic, echocardiographic and 201-thallium myocardial scintigraphic findings. Jpn Circ J 1990; 54: 354-360.
13. Hamada M, Ohtani T, Sekiya M, Fujiwara Y, Sumimoto T, Hiwada K, et al. Serum creatine kinase MM isoforms in hypertrophic cardiomyopathy. Clin Sci 1991; 81: 723-726.
14. Tanaka M, Fujiwara H, Onodera T, Wu D-J, Matsuda M, Hamashima Y, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75: 1130-1139.
15. Hamada M, Matsuzaki K, Kazatani Y, Nishitani K, Daimon F, Ochi T, et al. Diagnostic significance of early diastolic time intervals in patients with hypertrophic cardiomyopathy and myocardial hypertrophy due to essential hypertension. Jpn Circ J 1983; 47: 522-527.
16. Anan R, Shono H, Kisanuki A, Arima S, Nakao S, Tanaka H. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 1998; 98: 391-397.
17. Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, et al. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001; 38: 315-321.
18. Erdmann J, Raible J, Maki-Abadi J, Hummel M, Hammann J, Wollnik B, et al. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carries with hypertrophic cardiomyopathy. J Am Coll Cardiol 2001; 38: 322-330.